NEW YORK (GenomeWeb) – Genomic Health announced today that national Medicare contractor Palmetto GBA has issued a favorable final local coverage determination expanding coverage of the company's Oncotype DX prostate cancer test.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.
This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.
This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.